Study of HDL function in patients with vasospastic angina.

Study of HDL function in patients with vasospastic angina. - Vasospastic angina and HDL function

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000020942

Enrollment

200

Registered

2016-02-09

Start date

2016-02-09

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ischemic heart disease

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) Patients who have been diagnosed as vasospastic angina with acetylcholine provocation test. 2) Patients who are planned to undergo acetylcholine provocation test due to suspicion of vasospastic angina 3)Patients who gave written informed consent

Exclusion criteria

Exclusion criteria: 1) Patients who have residual organic coronary obstructive lesions which need revascularization 2) End-stage renal disease (eGFR<30 ml/min) except for patients under hemodialysis 3) Subjects who are pregnant or hope to be pregnant 4) Shock 5) Subjects whose doctor in charge do not agree to join the trial

Design outcomes

Primary

Measure	Time frame
HDL function (the ability of cholesterol efflux, antioxidant effects, anti-inflammatory effects, endothelial function)	—

Secondary

Measure	Time frame
Blood analyses including Hemoglobin A1c levels, Lipid profile, renal function, hepatic function, etc.	—

Countries

Japan

Contacts

Public ContactHirotaka Ezaki

Tokorozawa Heart Center Department of Cardiology

hirotakaezaki@gmail.com04-2940-8611

Outcome results